Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis:an Ultrasound/Magnetic Resonance Imaging Study
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
In rheumatoid arthritis patients with active disease despite optimal treatment with
methotrexate, the main objective of this pilot study is to use advance imaging tools such as
magnetic resonance imaging and ultrasound to evaluate which treatment option is more
efficacious: initiating methotrexate/sulfasalazine combination therapy, or switching to
leflunomide monotherapy